The Sensitivity of a Voluntary Drug Experience Reporting System

Burkholder DF , Adverse drug effects and their impact on patient care. A review of the problem. Drug Intell Clin Pharm 1979; 13: 421–4.

McQueen EG , Voluntary reporting systems. In: Gross FH Inman WH , eds. Drug monitoring. New York: Academic Press, 1977: 11–16.

Post-marketing surveillance — A preview of IMS studies. IMS Pharmaceutical Market Letter 1979 (Nov): 8–9.

Boman G. The Swedish report system. In: Ducrot H , eds. Computer AID to drug therapy and to drug monitoring Proceedings of the IFIP working conference. New York: Elsevier/North Holland, 1978: 115–6.

Wardell WM , Post-marketing surveillance of new drugs: 1. review of objectives and methodology. J Clin Pharmacol 1979; 19: 85–94.

Dunne JF , Spontaneous reports of adverse reactions to drugs. In: Ducrot H , eds. Computer AID to drug therapy and to drug monitoring. Proceedings of the IFIP working conference. New York: Elsevier/North Holland, 1978;105–8.

Farina JC , Computer tools in spontaneous reports of adverse drug reactions: A multi-national company approach. In: Ducrot H , eds. Computer AID to drug therapy and to drug monitoring. Proceedings of the IFID working conference. New York: Elsevier/North Holland, 1978: 117–23.